Search the Newsreel

Verisk Analytics, Inc. $VRSK Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. Has $16.10 Million Stake in STERIS plc $STE

Assenagon Asset Management S.A. significantly increased its stake in STERIS plc by 56.5% during the second quarter, now holding 76,440 shares valued at $16.10 million. Institutional investors collectively own 94.69% of STERIS, which recently exceeded earnings expectations with $2.59 EPS and $1.49 billion in …

Aeris Environmental (ASX:AEI) Rises Ahead Of Next Financial Update

L1 Capital Pty Ltd Trims Anteris Technologies Global Corp (AVR) Stake

Verisk Analytics Inc. stock underperforms Monday when compared to competitors

Verisk Analytics Inc. (VRSK) shares dropped 5.55% on Monday, closing at $181.18, despite a broader market decline with the S&P 500 Index and Dow Jones Industrial Average also falling. This performance marked the end of a two-day winning streak for the company's stock.

Insider at Company (NASDAQ: VRSN) files to sell 500 common shares

Thomas C. Indelicarto, an insider at VeriSign Inc. (NASDAQ: VRSN), has filed a Form 144 indicating a proposed sale of 500 shares of common stock with an approximate value of $146,175.00, to be sold on or after August 10, 2026. The filing also details …

Arteris (NASDAQ:AIP) Shares Down 7.2% - Time to Sell?

Arteris (NASDAQ:AIP) shares dropped 7.2% to $27.63 on Monday, trading below its 50-day moving average, though above its 200-day average. The company recently missed quarterly EPS expectations, reporting a $0.10 loss per share against a projected $0.04 loss, despite slightly exceeding revenue forecasts. Despite …

We Think You Can Look Beyond Verisk Analytics' (NASDAQ:VRSK) Lackluster Earnings

This article suggests that investors should not be overly concerned by Verisk Analytics' recent disappointing earnings, as the company is expected to see a significant rebound in earnings per share (EPS) over the next couple of years. Despite falling short of analyst estimates in …

Why is Verisk Analytics stock sliding today?

Verisk Analytics (VRSK) stock fell 5.6% after a Delaware Chancery Court ruling compelled the company to proceed with its $2.35 billion acquisition of AccuLynx, a deal Verisk had attempted to terminate in December 2025. The court also awarded damages to AccuLynx, and the transaction …

Verisk Analytics (NASDAQ:VRSK) Shares Gap Down - Here's Why

Verisk Analytics (NASDAQ:VRSK) shares gapped down by about 5% on Monday, opening at $180.90 after closing at $191.82, despite exceeding quarterly earnings expectations with $1.98 EPS and $806.3 million in revenue. The company also declared a quarterly dividend of $0.50 per share, while insiders …

Verisk 'strongly Disagrees' With Delaware Court Ruling On AccuLynx

(RTTNews) - Verisk Analytics, Inc. (VRSK) said on Monday it "strongly disagrees" with a Delaware Chancery Court ruling regarding AccuLynx, and is evaluating options including a possible appeal. "We appreciate the expedited response from the court but strongly disagree with the decision," the data …

L1 Capital Reports Sale of 174,721 Anteris Technologies Shares at $8.10 Each

L1 Capital Pty Ltd filed a Form 4 with the SEC on August 10, 2026, disclosing the sale of 174,721 shares of common stock in Anteris Technologies Global Corp. (NASDAQ: AVR). The transaction occurred on August 6, 2026. The article indicates a sale price …

Court rejects Verisk plan to cancel $2.35 billion merger

A Delaware Chancery Court has rejected Verisk's attempt to terminate its $2.35 billion merger with AccuLynx, ordering Verisk to proceed with "commercially reasonable efforts" to obtain regulatory approval. The ruling stemmed from Verisk's handling of an FTC antitrust review, which Verisk initiated by attempting …

L1 Capital (AVR) trims Anteris stake, retains 5.44M shares and CDI warrants

L1 Capital Pty Ltd, a significant owner of Anteris Technologies Global Corp. (AVR), reported an indirect sale of 174,721 shares of common stock on August 6, 2026, at $8.10 per share. Following this transaction, L1 Capital maintains an indirect holding of 5,439,000 shares of …

Xeris Biopharma’s Rising Revenue And Wider Losses Could Be A Game Changer For XERS

Verisk Responds to Delaware Chancery Court Ruling Regarding AccuLynx

Verisk (Nasdaq: VRSK) has issued a statement expressing strong disagreement with a recent Delaware Chancery Court ruling concerning AccuLynx. The company acknowledges the court's expedited response but is currently evaluating its options, including a possible appeal. Verisk is a leading data analytics and technology …

AMERISAFE, Inc. (AMSF) Stock Forecasts

AMERISAFE, Inc. (AMSF) recently had its rating decreased to a SELL by Argus on August 5, 2026. The company specializes in workers' compensation insurance for hazardous industries like construction and trucking. The current stock price is $28.59.

VeriSign, Inc. (NASDAQ:VRSN) Given Average Rating of "Buy" by Analysts

VeriSign, Inc. (NASDAQ:VRSN) has received an average "Buy" rating from six research firms, with an average 12-month price target of $328.75. The company recently surpassed quarterly earnings and revenue estimates, reporting $2.38 EPS and $434.6 million in revenue, a 6% year-over-year increase. VeriSign also …

Arteris, Inc. (NASDAQ:AIP) Given Consensus Rating of "Moderate Buy" by Brokerages

Arteris, Inc. (NASDAQ:AIP) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $41.00. While the company exceeded revenue expectations in the second quarter and provided strong third-quarter and full-year guidance, it also reported a larger-than-expected loss per …

Ameris Bank Strengthens S.C. Leadership with Market Presidents in Midlands, Charleston and Greenville

Ameris Bank has appointed new market presidents in South Carolina to strengthen its leadership in key growth areas: Midlands, Charleston, and Greenville. Marvin Robinson will lead the Midlands market, P.J. Watson will head the Charleston market, and Dustin Morris has been promoted to lead …

Did Arteris' (AIP) Raised 2026 Outlook and AI Wins Just Recast Its Investment Narrative?

Arteris, Inc. (AIP) recently reported its second-quarter 2026 results, showing increased revenue and a wider net loss, but also raised its full-year 2026 revenue outlook. The company highlighted record contract values, significant AI and data center design wins, and new capital raised, which strengthens …

VRSK Looks 39.9% Undervalued on GF Value™ Amid Legal Acquisition Mandate

Verisk Analytics (NASDAQ: VRSK) has been deemed 39.9% undervalued according to GuruFocus's GF Value™ after a Delaware judge mandated the completion of its $2.35 billion acquisition of AccuLynx. The company boasts strong fundamentals with a GF Score™ of 82/100, driven by excellent growth and …

Verisk Analytics (VRSK) Q2 Update Puts Its Pricey Valuation Back In Focus

Verisk Analytics (VRSK) Q2 2026 results show continued revenue growth and new AI initiatives, leading to renewed focus on its valuation. Despite recent stock gains and strong business fundamentals, Simply Wall St's narrative suggests the company is significantly overvalued at $191.82 compared to a …

Ameris Bancorp $ABCB Shares Purchased by Renaissance Technologies LLC

Renaissance Technologies LLC significantly increased its stake in Ameris Bancorp ($ABCB) by 129.9% in the first quarter, now owning 44,069 shares valued at $3.44 million. Despite this institutional interest, Ameris Bancorp missed its Q1 earnings and revenue estimates and maintains a quarterly dividend of …

STERIS Q1 Earnings Call Highlights

Arteris Inc (AIP) Earnings Forecast: Future EPS & Revenue Growth Estimates

STERIS (STE) Stock Faces Valuation Scrutiny After Margin Gains And Higher Capex

Ameris Bancorp (ABCB) Stock Forecasts

Argus has raised its target price for Ameris Bancorp (ABCB) to $99.00. The company operates as a bank holding company through its subsidiary, Ameris Bank, with branches across Georgia, Alabama, Florida, and South Carolina. The current stock price for ABCB is $87.73.

Behavioral Patterns of AMSF and Institutional Flows

This article analyzes Amerisafe Inc. (NASDAQ: AMSF) using AI models to identify behavioral patterns and institutional flows. It suggests a near-term neutral sentiment, potentially pausing mid and long-term weakness, and highlights an exceptional short setup with a 30.1:1 risk-reward ratio. The analysis provides specific …

Precision Trading with Ameris Bancorp (ABCB) Risk Zones

This article provides a precision trading analysis for Ameris Bancorp (ABCB), indicating divergent sentiment across all time horizons and suggesting choppy conditions. It highlights an exceptional 18.3:1 risk-reward short setup and outlines three institutional trading strategies tailored for different risk profiles: Position Trading, Momentum …

Did STERIS’ (STE) Record Chemistries Bet and Dividend Hike Just Recast Its Earnings Narrative?

STERIS plc (STE) recently reported strong Q1 fiscal 2027 results, including increased sales and earnings, a reaffirmed full-year outlook, and its 21st consecutive annual dividend increase. The company also announced a significant US$600 million investment in a new chemistries Center of Excellence in North …

Verisk Analytics, Inc. (VRSK) Stock Forecasts

This article provides a stock forecast for Verisk Analytics, Inc. (VRSK), a data and analytics provider for property-casualty insurers. It highlights that Verisk's earnings were mostly steady in the second quarter and includes a summary of the company's background. The report also lists related …

Anteris Technologies Global Corp (ASX: AVR) Share Price Update: Stock Rises After Market Close as Health Care Index Ends Lower

Anteris Technologies Global Corp (ASX: AVR) saw its shares increase by approximately 5.19% to close at $11.55 on August 7, 2026, with a trading volume of 14,907 shares and a market capitalization of $174.72 million. This rise occurred despite the broader S&P/ASX 200 Health …

Xeris Biopharma Holdings Inc (XERS) Stock News Today

This article provides current stock information for Xeris Biopharma Holdings Inc (XERS) including its recent closing price, market capitalization, and P/E ratio. It highlights that the company's stock experienced a gain of 7.74% and indicates that more news and earnings updates are expected soon …

Arteris, Inc. Stock 12‑Month Price Target Raised to $41, Implies 30% Upside

The average 12-month price target for Arteris, Inc. (AIP) stock has been raised from $39.33 to $41 by 6 analysts, with forecasts ranging from $38 to $50 per share. This new target suggests a potential upside of approximately 30% from the Aug. 6 closing …

Ameris Bancorp (ABCB) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Ameris Bancorp (ABCB), detailing its current earnings forecast score, average price target from analysts, and a peer comparison within the Banking Services industry. It also includes expected revenue and EPS for upcoming quarters, as well as an …